Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 5;8(3):645–655. doi: 10.1002/acn3.51308

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Proinflammatory cytokine/chemokine and neopterin concentrations in CSF from patients with FIRES and controls. (A): CSF neopterin levels were measured in samples from patients with FIRES and patients with noninflammatory neurological disease (NIND) using HPLC. FIRES, N = 6; NIND, N = 13. (B)–(G): CSF levels of (B) CXCL‐10, (C) CXCL‐9, (D) IFN‐γ, (E) IL‐1β, (F) IL‐6, and (G) IL‐8 measured using a multiplexed immunoassay in samples from patients with FIRES and epilepsy. FIRES, N = 6; Epilepsy, N = 12. Each dot represents the cytokine/chemokine or neopterin levels of each patient. Bars express the median and interquartile range.